08 Jan 2026 by Ludwig Boltzmann
How can medicines work exactly where they are needed?
For a recent article in Chemiereport, Sylvia Maier-Kubala visited the institute and profiled the research conducted by the team led by institute director Nicole Meisner-Kober.
The research of the LBI for Nanovesicular Precision Medicine at the Paris Lodron University of Salzburg focuses on nanovesicles, the body’s own membrane-enclosed vesicles, and their use as high-precision drug carriers and their application in regenerative medicine. Chemiereport, Austria’s magazine for business, technology and research, has published an article about our work.
Read the full article here.
